John Oyler - Oct 8, 2024 Form 4 Insider Report for BeiGene, Ltd. (BGNE)

Signature
/s/ Qing Nian, as Attorney-in-Fact
Stock symbol
BGNE
Transactions as of
Oct 8, 2024
Transactions value $
-$3,756,092
Form type
4
Date filed
10/10/2024, 05:48 PM
Previous filing
Jun 26, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction BGNE American Depositary Shares Sale -$359K -1.57K -25.34% $229.25 4.61K Oct 8, 2024 Direct F6, F7, F8
transaction BGNE American Depositary Shares Sale -$402K -1.75K -37.9% $230.05 2.86K Oct 8, 2024 Direct F6, F7, F9
transaction BGNE American Depositary Shares Sale -$52.9K -229 -8% $231.05 2.63K Oct 8, 2024 Direct F6, F7, F10
transaction BGNE American Depositary Shares Sale -$8.85K -38 -1.44% $233.00 2.6K Oct 8, 2024 Direct F6, F7
transaction BGNE American Depositary Shares Sale -$100K -428 -16.49% $234.27 2.17K Oct 8, 2024 Direct F6, F7, F11
transaction BGNE American Depositary Shares Sale -$299K -1.27K -58.67% $235.41 896 Oct 8, 2024 Direct F6, F7, F12
transaction BGNE American Depositary Shares Sale -$212K -896 -100% $236.37 0 Oct 8, 2024 Direct F6, F7, F13
transaction BGNE American Depositary Shares Sale -$581K -2.54K -25.35% $229.25 7.47K Oct 8, 2024 See Footnote F3, F6, F7, F8
transaction BGNE American Depositary Shares Sale -$650K -2.83K -37.87% $230.05 4.64K Oct 8, 2024 See Footnote F3, F6, F7, F9
transaction BGNE American Depositary Shares Sale -$85.7K -371 -8% $231.04 4.27K Oct 8, 2024 See Footnote F3, F6, F7, F10
transaction BGNE American Depositary Shares Sale -$14.4K -62 -1.45% $233.00 4.21K Oct 8, 2024 See Footnote F3, F6, F7
transaction BGNE American Depositary Shares Sale -$163K -694 -16.5% $234.27 3.51K Oct 8, 2024 See Footnote F3, F6, F7, F11
transaction BGNE American Depositary Shares Sale -$485K -2.06K -58.64% $235.41 1.45K Oct 8, 2024 See Footnote F3, F6, F7, F12
transaction BGNE American Depositary Shares Sale -$343K -1.45K -100% $236.37 0 Oct 8, 2024 See Footnote F3, F6, F7, F13
holding BGNE Ordinary Shares 1.68M Oct 8, 2024 Direct
holding BGNE Ordinary Shares 482K Oct 8, 2024 See Footnote F1
holding BGNE Ordinary Shares 7.73M Oct 8, 2024 See Footnote F2
holding BGNE Ordinary Shares 28.2M Oct 8, 2024 See Footnote F3
holding BGNE Ordinary Shares 9.55M Oct 8, 2024 See Footnote F4
holding BGNE Ordinary Shares 102K Oct 8, 2024 See Footnote F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id Content
F1 These securities are held by the P&O Trust, the beneficiaries of which include the Reporting Person's child and others, for which the Reporting Person disclaims beneficial ownership.
F2 These securities are held in a grantor retained annuity trust, of which the Reporting Person's father is a trustee, for which the Reporting Person disclaims beneficial ownership.
F3 These securities are held by Oyler Investment LLC, of which 99% of the the limited liability company interest owned by a grantor retain annuity trust, of which the Reporting Person's father is a trustee, for which the Reporting Person disclaims beneficial ownership.
F4 These securities are held for the benefit of the Reporting Person in a Roth IRA PENSCO trust account.
F5 These securities are held by The John Oyler Legacy Trust for the benefit of the Reporting Person's minor child, for which the Reporting Person disclaims beneficial ownership.
F6 Each American Depositary Share represents 13 Ordinary Shares.
F7 The sale was effected pursuant to a Rule 10b5-1 trading plan adopted on December 12, 2023.
F8 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $229.00 to $229.49, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares sold at each separate price.
F9 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $230.00 to $230.20, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares sold at each separate price.
F10 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $231.00 to $231.09, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares sold at each separate price.
F11 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $234.00 to $234.97, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares sold at each separate price.
F12 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $235.01 to $235.99, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares sold at each separate price.
F13 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $236.22 to $236.60, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares sold at each separate price.